arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

STAAR Surgical Company

STAA Health Care Ophthalmic Goods
$22.49
▲ +0.8% Today
as of Oct 22, 16:52 ET
Last 30 days -2.51% Sep 14 → Oct 22
$18.76 $19.92 $21.07 $22.23 $23.39 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$21.61
High
$22.68
Low
$21.61
Volume
$414,995
Avg Vol
$1M
Mkt Cap
$1.1B
P/E (TTM)
48.34
Beta
—
52w High
$35.87
52w Low
$15.59
Div Yield
—
Shares Out
$50M

Recent Press Releases & News last 60 days · 25 items

Oct 21 · 20:01 PR Business Wire
STAAR Surgical to Host Third Quarter 2026 Earnings Results Call and Webcast on November 4, 2026
Oct 14 · 09:17 Simply Wall St.
Will New Business Development VP Hire and Lens Expansion Strategy Change STAAR Surgical's (STAA) Narrative
Oct 13 · 11:15 Simply Wall St.
Has STAAR Surgical (STAA) Fallen Far Enough To Look Cheap?
▸ Show all 25 press releases & news Free account →

STAA earnings at a glance

STAAR Surgical Company (STAA) is scheduled to report earnings on Wednesday, November 4, 2026 — in 12 days. Analysts expect earnings per share of $0.05, compared with $0.30 in the same quarter last year (-83%). The options market is pricing a move of about ±7.5% after the report, a range of roughly $20.81 to $24.17 from today's $22.49. Over its last 6 reports the stock rose the next day 5 times and fell 1, moving ±2.8% on average; after the most recent report on Aug 12, 2026 it moved -0.3%. That means options currently expect more movement than STAA has typically delivered. STAA beat the consensus EPS estimate in 5 of its last 6 reported quarters. Implied volatility is currently 63%. The share price of $22.49 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$16
$36
34% of range
Avg surprise (last 6)
+227.0%
Avg reaction (last 6)
+2.7%
83% positive
Latest IV / EM
63%
EM ±7.5% · $23 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.67$-0.43$-0.19$0.06$0.30 Actual $0.05Actual $0.12Actual $0.10Actual $-0.07Actual $0.15Actual $0.20Actual $-0.64Est $-0.66Actual $-0.23Est $-0.67Actual $0.30Est $0.05Actual $-0.13Est $0.03Actual $0.29Est $-0.03Actual $0.18Est $0.05 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258KMar/2026Jun/2026
Revenue vs Net Income Revenue Net income
$-54M$-16M$23M$61M$99M Sep 24Mar 25Jun 25Sep 25Apr 26Jul 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed Aug 12, 2026Jun/2026 $0.18 $0.05 +260.0% +121.7% -0.3% earnings
Wed May 13, 2026Mar/2026 $0.29 $-0.03 +1,067% +145.3% +8.9% earnings
Tue Mar 3, 20268K 2026-03-03 $-0.13 $0.03 -533.3% — +1.6% earnings
Wed Nov 5, 2025Sep/2025 $0.30 $0.05 +500.0% — +5.5% earnings
Wed Aug 6, 2025Jun/2025 $-0.23 $-0.67 +65.7% — +0.2% earnings
Wed May 7, 2025Mar/2025 $-0.64 $-0.66 +3.0% — +0.5% earnings
Fri Sep 27, 2024Sep 2024 $0.20 — — — — financials
Fri Jun 28, 2024Jun 2024 $0.15 — — — — financials
Fri Mar 29, 2024Mar 2024 $-0.07 — — — — financials
Fri Sep 29, 2023Sep 2023 $0.10 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.12 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.05 — — — — financials

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Nov 4, 2026Sep/2026OTHER $0.05$0.30 -83.3%

Financials

Income statement (quarterly)

MetricJul 2026Apr 2026Jan 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$94M$94M—$95M$44M$43M—$89M
Cost of revenue$24M$25M—$17M$12M$15M—$20M
Gross profit$70M$69M—$78M$33M$28M—$68M
Operating income$10M$8M—$18M$-30M$-57M—$6M
Net income$8M$5M—$9M$-17M$-54M—$10M
EPS (diluted)$0.16$0.10—$0.18$-0.34$-1.10—$0.20

Balance sheet (quarterly)

MetricJul 2026Apr 2026Jan 2026Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$149M$132M$153M$176M$167M$173M$144M$164M
Inventory————————
Total current assets$342M$312M$312M$321M$293M$326M$368M$397M
Total assets$475M$451M$452M$456M$438M$457M$510M$538M
Long-term debt————————
Total liabilities$110M$99M$107M$103M$101M$107M$112M$109M
Total equity$365M$352M$344M$354M$337M$350M$397M$428M

Implied volatility — last 90 days

31%231%431%631%831% Jun 07 — IV 83% · EM ±11.5%Jun 08 — IV 56% · EM ±7.4%Jun 09 — IV 57% · EM ±7.2%Jun 10 — IV 61% · EM ±7.2%Jun 11 — IV 84% · EM ±9.3%Jun 12 — IV 121% · EM ±12.3%Jun 15 — IV 197% · EM ±14.3%Jun 16 — IV 155% · EM ±9.2%Jun 17 — IV 234% · EM ±9.8%Jun 19 — IV 50% · EM ±11.2%Jun 22 — IV 55% · EM ±11.5%Jun 23 — IV 51% · EM ±10.5%Jun 24 — IV 78% · EM ±15.6%Jun 25 — IV 71% · EM ±13.9%Jun 26 — IV 50% · EM ±9.6%Jun 29 — IV 51% · EM ±9.1%Jun 30 — IV 55% · EM ±9.5%Jul 01 — IV 94% · EM ±15.6%Jul 02 — IV 60% · EM ±9.6%Jul 03 — IV 62% · EM ±9.6%Jul 06 — IV 76% · EM ±10.5%Jul 07 — IV 80% · EM ±10.5%Jul 08 — IV 70% · EM ±8.8%Jul 09 — IV 68% · EM ±8.0%Jul 10 — IV 47% · EM ±5.2%Jul 13 — IV 43% · EM ±3.6%Jul 14 — IV 48% · EM ±3.5%Jul 15 — IV 107% · EM ±6.3%Jul 16 — IV 831% · EM ±34.7%Jul 20 — IV 66% · EM ±15.6%Jul 21 — IV 62% · EM ±14.4%Jul 22 — IV 68% · EM ±15.6%Jul 23 — IV 67% · EM ±15.0%Jul 24 — IV 66% · EM ±14.5%Jul 27 — IV 73% · EM ±15.3%Jul 28 — IV 62% · EM ±12.7%Jul 29 — IV 91% · EM ±18.2%Jul 30 — IV 67% · EM ±13.1%Jul 31 — IV 83% · EM ±15.8%Aug 03 — IV 99% · EM ±17.5%Aug 04 — IV 82% · EM ±14.2%Aug 05 — IV 71% · EM ±11.8%Aug 06 — IV 84% · EM ±13.5%Aug 07 — IV 67% · EM ±10.5%Aug 10 — IV 83% · EM ±11.4%Aug 11 — IV 93% · EM ±12.2%Aug 12 — IV 120% · EM ±15.1%Aug 13 — IV 52% · EM ±6.1%Aug 14 — IV 61% · EM ±6.8%Aug 17 — IV 63% · EM ±5.3%Aug 18 — IV 65% · EM ±4.7%Aug 19 — IV 74% · EM ±4.4%Aug 20 — IV 42% · EM ±1.7%Aug 24 — IV 66% · EM ±13.8%Aug 25 — IV 42% · EM ±8.6%Aug 26 — IV 39% · EM ±7.8%Aug 27 — IV 40% · EM ±7.8%Aug 28 — IV 31% · EM ±6.0%Aug 31 — IV 37% · EM ±6.6%Sep 01 — IV 38% · EM ±6.6%Sep 02 — IV 63% · EM ±10.6%Sep 03 — IV 44% · EM ±7.1%Sep 04 — IV 76% · EM ±11.8%Sep 07 — IV 85% · EM ±11.8%Sep 08 — IV 55% · EM ±7.2%Sep 09 — IV 61% · EM ±7.6%Sep 11 — IV 54% · EM ±6.0%Sep 14 — IV 71% · EM ±6.0%Sep 15 — IV 62% · EM ±4.5%Sep 16 — IV 72% · EM ±4.2%Sep 17 — IV 279% · EM ±11.7%Sep 21 — IV 42% · EM ±8.7%Sep 22 — IV 51% · EM ±10.5%Sep 23 — IV 49% · EM ±9.7%Sep 24 — IV 55% · EM ±10.8%Sep 25 — IV 50% · EM ±9.5%Sep 28 — IV 45% · EM ±8.0%Sep 29 — IV 46% · EM ±7.9%Sep 30 — IV 53% · EM ±8.9%Oct 01 — IV 55% · EM ±8.8%Oct 02 — IV 49% · EM ±7.7%Oct 06 — IV 51% · EM ±6.8%Oct 07 — IV 49% · EM ±6.1%Oct 08 — IV 63% · EM ±7.5%

Sector peers

EYE
National Vision Holdings, Inc.
$1.3B $18.87+5.1%
RXST
RxSight, Inc.
$200M $5.08+4.1%
LUCY
Innovative Eyewear, Inc.
$8M $0.86+3.6%
WRBY
Warby Parker Inc.
$3.1B $25.67+0.2%
BLCO
Bausch + Lomb Corporation
$6.2B $17.43+3.0%
COO
The Cooper Companies, Inc.
$13.6B $61.65+4.3%

STAA earnings FAQ

When is STAA's next earnings date?

STAAR Surgical Company is expected to report on November 4, 2026.

What is STAA's expected move for earnings?

Options currently price a move of about ±7.5%, or $1.68 per share either way from $22.49.

How does STAA stock usually react to earnings?

Across the last 6 reports the average next-day move was ±2.8%, up 5 times and down 1 times.

What EPS are analysts expecting from STAAR Surgical Company?

The consensus estimate is $0.05 per share, versus $0.30 a year ago.

What is STAA's implied volatility?

STAA's at-the-money implied volatility is about 63% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in